نتائج البحث - "Richard Lizambri"

1

Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial

المؤلفون: Mon-Gy Chen, Marc Alfonsi, Laura Cerezo, Paolo Foa, Michael Henke, Lara Emmerson, Richard Lizambri, Etienne Bardet, Michaela Salzwimmer, Jordi Giralt, Dietmar Berger

المصدر: Journal of Clinical Oncology. 29:2815-2820

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Intention-to-treat analysis, business.industry, Head and neck cancer, Placebo-controlled study, medicine.disease, Placebo, Surgery, law.invention, Oncology, Palifermin, Randomized controlled trial, law, medicine, Mucositis, business, Chemoradiotherapy, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f603a226b57bcc44dbe087d1c01831e3
https://doi.org/10.1200/jco.2010.32.4103

View record in OpenAIRE

2

Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study

المؤلفون: Sabine Reinisch, Györgyi Muraközy, Dietmar Berger, Quynh-Thu Le, Harold Kim, Michael Henke, Charles J. Schneider, May Mo, Krzysztof Składowski, Richard Lizambri, Yuhchyau Chen, Mon Gy Chen, Michael Hickey

المصدر: Journal of Clinical Oncology. 29:2808-2814

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Randomization, Intention-to-treat analysis, business.industry, Head and neck cancer, Placebo-controlled study, medicine.disease, Placebo, Gastroenterology, Surgery, Oncology, Palifermin, Internal medicine, medicine, Mucositis, business, Chemoradiotherapy, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0959ae7433539affb2e34a32fef4e0d8
https://doi.org/10.1200/jco.2010.32.4095

View record in OpenAIRE

3

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial

المؤلفون: Kiyoshi Ando, Richard Lizambri, Mineo Kurokawa, Satoshi Hashino, Yoshiaki Tomiyama, Yukari Shirasugi, Yuji Yonemura, Kensuke Usuki, Shinichiro Okamoto, Koji Miyazaki, Helen Wei, Keita Kirito, Shinichiro Mori, Koji Iwato

المصدر: International Journal of Hematology. 94:71-80

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d1e5a750ef52888f01b906961b4a7c
https://doi.org/10.1007/s12185-011-0886-8

View record in OpenAIRE

4

An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)

المؤلفون: Yukari Shirasugi, Mineo Kurokawa, Shinichiro Okamoto, Helen Wei, Kiyoshi Ando, Richard Lizambri, Satoshi Hashino, Kensuke Usuki, Shinichiro Mori, Haruhiko Ninomiya, Keita Kirito, Yuji Yonemura, Koji Iwato, Koji Miyazaki, Yoshiaki Tomiyama

المصدر: International journal of hematology. 95(6)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::000dbac8bb3d03c2a6359dd962ddd05e
https://pubmed.ncbi.nlm.nih.gov/22532046

View record in OpenAIRE

5

A phase 3, multicenter, randomized, double-blind, placebo-controlled study of rilotumumab in combination with cisplatin and capecitabine (CX) as first-line therapy for Asian patients (pts) with advanced MET-positive gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The RILOMET-2 trial

المؤلفون: Toshihiko Doi, Yoon-Koo Kang, Rajul K. Jain, Yizhou Jiang, Richard Lizambri, Kei Muro

المصدر: Journal of Clinical Oncology. 33:TPS226-TPS226

مصطلحات موضوعية: Cisplatin, Cancer Research, medicine.medical_specialty, business.industry, Placebo-controlled study, Phases of clinical research, Rilotumumab, medicine.disease, Gastroenterology, Surgery, Double blind, Capecitabine, Oncology, Internal medicine, medicine, Adenocarcinoma, business, MET Positive, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8486277a6ed897f89df1df665ce923ee
https://doi.org/10.1200/jco.2015.33.3_suppl.tps226

View record in OpenAIRE

6

Safety, tolerability, and pharmacokinetics (PK) of rilotumumab (R) combined with cisplatin (C) and capecitabine (X) in Japanese patients (pts) with MET-positive metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

المؤلفون: Elwyn Loh, Yoshito Komatsu, Hirofumi Yasui, Kensei Yamaguchi, Richard Lizambri, Takako Eguchi Nakajima, Yilong Zhang, Toshihiko Doi, Tomohiro Nishina, Rui Tang, Kei Muro

المصدر: Journal of Clinical Oncology. 32:4051-4051

مصطلحات موضوعية: Cisplatin, Cancer Research, medicine.drug_class, business.industry, Rilotumumab, Pharmacology, medicine.disease, Monoclonal antibody, Capecitabine, Oncology, Pharmacokinetics, medicine, Cancer research, Adenocarcinoma, Hepatocyte growth factor, business, MET Positive, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1ae0448d06c4536b36c20ab3f802d99d
https://doi.org/10.1200/jco.2014.32.15_suppl.4051

View record in OpenAIRE

7

Palifermin Reduces Severe Oral Mucositis in Subjects with Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy

المؤلفون: Yuhchyau Chen, Charles J. Schneider, Michael Henke, Q.T. Le, Krzysztof Składowski, S. Reinisch, G. Muraközy, Richard Lizambri, Hyeong Reh Choi Kim, M. Hickey

المصدر: International Journal of Radiation Oncology*Biology*Physics. 72:S32-S33

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Radiation, business.industry, Head and neck cancer, Locally advanced, medicine.disease, Surgery, Oncology, Palifermin, medicine, Mucositis, Radiology, Nuclear Medicine and imaging, business, Chemoradiotherapy, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fa9237525bf7903e5061dd0e47fb8018
https://doi.org/10.1016/j.ijrobp.2008.06.838

View record in OpenAIRE

8

Safety, tolerability, and pharmacokinetics (PK) of rilotumumab in Japanese patients (pts) with advanced solid tumors

المؤلفون: Richard Lizambri, Yilong Zhang, Toshihiko Doi, Hirofumi Yasui, Rui Tang, Elwyn Loh

المصدر: Journal of Clinical Oncology. 32:130-130

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Combination therapy, business.industry, Standard treatment, Cancer, Rilotumumab, Pharmacology, medicine.disease, Capecitabine, Pharmacokinetics, Tolerability, Internal medicine, medicine, business, medicine.drug, Epirubicin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::46b03d044dfcfe85d374ad79048d5034
https://doi.org/10.1200/jco.2014.32.3_suppl.130

View record in OpenAIRE

9

Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP)

المؤلفون: Romeo A. Mandanas, Richard Lizambri, Roger M. Lyons, Jean-François Viallard, Marc Michel, Xuena Wang, Jeffrey S. Wasser, Ralph V. Boccia, Ingrid Pabinger

المصدر: Blood. 118:3282-3282

مصطلحات موضوعية: Response rate (survey), Pediatrics, medicine.medical_specialty, Romiplostim, business.industry, Immunology, Cell Biology, Hematology, Off-label use, Biochemistry, Clinical trial, Prednisone, hemic and lymphatic diseases, Concomitant, Medicine, Rituximab, business, Adverse effect, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::38529fe33f83483f515ce904b9459733
https://doi.org/10.1182/blood.v118.21.3282.3282

View record in OpenAIRE

10

Evaluation of Romiplostim In a Randomized Placebo-Controlled Phase 3 Study of a Japanese Population with Chronic Immune Thrombocytopenia (ITP)

المؤلفون: Koji Iwato, Satoshi Hashino, Helen Wei, Kensuke Usuki, Kiyoshi Ando, Richard Lizambri, Yuji Yonemura, Shinichiro Mori, Yoshiaki Tomiyama, Keita Kirito, Mineo Kurokawa, Yukari Shirasugi, Koji Miyazaki, Shinichiro Okamoto

المصدر: Blood. 116:3704-3704

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a27f4a1d92081ae21dd3dbaa5d84a7c6
https://doi.org/10.1182/blood.v116.21.3704.3704

View record in OpenAIRE

11

The Effects of Romiplostim or Standard of Care (SOC) on Splenectomy and Treatment Failure of Patients Who Had Immune Thrombocytopenia (ITP) for Less Than or Equal to One Year

المؤلفون: B. Gail Macik, David J. Kuter, Ingrid Pabinger, Ralph V. Boccia, Richard Lizambri, Xuena Wang, Dominik Selleslag, Francesco Rodeghiero, Mathias J. Rummel, Beng H. Chong

المصدر: Blood. 116:3702-3702

مصطلحات موضوعية: Response rate (survey), Pediatrics, medicine.medical_specialty, Romiplostim, business.industry, medicine.medical_treatment, Incidence (epidemiology), Immunology, Splenectomy, Cell Biology, Hematology, Biochemistry, Discontinuation, Treatment and control groups, Clinical endpoint, Medicine, business, Adverse effect, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b2ca79adde6cb7e239af0cf45b778f1a
https://doi.org/10.1182/blood.v116.21.3702.3702

View record in OpenAIRE

12

Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP)

المؤلفون: Xuena Wang, Romeo A. Mandanas, Dietmar Berger, Richard Lizambri, Ralph V. Boccia, Gail Macik, Roger M. Lyons

المصدر: Blood. 114:3510-3510

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Romiplostim, business.industry, Incidence (epidemiology), medicine.medical_treatment, Immunology, Splenectomy, Cell Biology, Hematology, Biochemistry, Treatment failure, Prior Therapy, Interquartile range, medicine, Adverse effect, business, Administration (government), medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6805ab5df6cef14100e7b8f7aa271e94
https://doi.org/10.1182/blood.v114.22.3510.3510

View record in OpenAIRE

13

Palifermin Reduces Dysphagia in Patients with Locally-advanced Unresected Non–small-cell Lung Cancer Undergoing Concurrent Chemoradiotherapy

المؤلفون: Yuhchyau Chen, Richard Lizambri, Dietmar Berger, M. Krzakowski, B. Massuti, G. Otterson, Helen Wei, W. Schuette

المصدر: International Journal of Radiation Oncology*Biology*Physics. 75:S114

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::16ae0000c12e1540ad22a1e6869c5808
https://doi.org/10.1016/j.ijrobp.2009.07.275

View record in OpenAIRE

14

Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small Cell Lung Cancer

المؤلفون: Richard Lizambri, Gregory A. Otterson, Yuhchyau Chen, Helen Wei, Bartomeu Massuti, Maciej Krzakowski, Dietmar Berger, Wolfgang Schuette

المصدر: Journal of Thoracic Oncology. (1):157-164

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Male, medicine.medical_specialty, Fibroblast Growth Factor 7, Lung Neoplasms, Paclitaxel, Phases of clinical research, Kaplan-Meier Estimate, Non-small cell, Placebo, Gastroenterology, Severity of Illness Index, Article, Disease-Free Survival, law.invention, Carboplatin, chemistry.chemical_compound, Randomized controlled trial, Double-Blind Method, law, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, Lung, Aged, business.industry, Chemoradiotherapy, Dysphagia, Middle Aged, medicine.disease, Surgery, Treatment Outcome, Oncology, Palifermin, chemistry, Disease Progression, Female, medicine.symptom, business, Deglutition Disorders, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbdde9c93e9c6a4ef4894cf74dd2dde

View record in OpenAIRE

تنقيح النتائج